These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9410329)

  • 41. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
    Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
    J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome.
    Roemeling S; Roobol MJ; de Vries SH; Wolters T; Gosselaar C; van Leenders GJ; Schröder FH
    Eur Urol; 2007 May; 51(5):1244-50; discussion 1251. PubMed ID: 17161520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Screening for early detection of prostate cancer (first experience in Israel)].
    Neheman A; Shotland Y; Metz Y; Stein A
    Harefuah; 2001 Jan; 140(1):4-10, 88, 87. PubMed ID: 11242898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
    Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Epidemiology of prostate cancer].
    Grosclaude P; Roumagnac M
    Ann Urol (Paris); 1992; 26(5):294-300. PubMed ID: 1485798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparison of the clinical features of uterine cervical cancers detected by mass screening and voluntary visit].
    Yoh S; Hasuo Y; Tanaka H; Yakushizi M; Sakurai T
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1949-57. PubMed ID: 3382243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prospective comparison of prostate cancer at autopsy and as a clinical event: the Hawaii Japanese experience.
    Stemmermann GN; Nomura AM; Chyou PH; Yatani R
    Cancer Epidemiol Biomarkers Prev; 1992; 1(3):189-93. PubMed ID: 1306104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostate cancer screening. Why the controversy?
    Walther PJ
    Surg Oncol Clin N Am; 1995 Apr; 4(2):315-34. PubMed ID: 7540938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. When is active surveillance the appropriate treatment for prostate cancer?
    Albertsen PC
    Acta Oncol; 2011 Jun; 50 Suppl 1():120-6. PubMed ID: 21604952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for cancer. Is it useful?
    Loefler IJ
    East Afr Med J; 1994 May; 71(5):323-7. PubMed ID: 7925066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Tumor screening with special reference to breast and prostate carcinoma].
    Jost LM
    Ther Umsch; 1997 Aug; 54(8):439-50. PubMed ID: 9381414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ongoing debates on localized prostate cancer: epidemiology, screening and stratification].
    Audenet F; Rouprêt M
    Prog Urol; 2011 May; 21 Suppl 3():S75-9. PubMed ID: 21616443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology of prostate cancer.
    Meikle AW; Smith JA
    Urol Clin North Am; 1990 Nov; 17(4):709-18. PubMed ID: 2219573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Screening for early diagnosis of prostatic cancer].
    Otnes B; Tveter KJ
    Tidsskr Nor Laegeforen; 1994 Jan; 114(2):157-60. PubMed ID: 7772094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cancer of the prostate. 1. Epidemiology].
    Mottet Auselo N; Costa P; Le Pellec L; Louis JF; Navratil H
    Prog Urol; 1995 Feb; 5(1):31-7. PubMed ID: 7536526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical preventive medicine in cancer diagnosis--proposal for a new cancer diagnostic system in an aging society].
    Ishimori A
    Rinsho Byori; 1993 Jun; 41(6):617-24. PubMed ID: 8361026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Epidemiology of cancer of the prostate. Descriptive study].
    Bravo MP; de Palacio A; del Rey Calero J
    Arch Esp Urol; 1990 May; 43(4):349-52. PubMed ID: 1696450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Impact of life expectancy on the clinical significance and curability of prostate cancer].
    Egawa S
    Nihon Rinsho; 1998 Aug; 56(8):2103-7. PubMed ID: 9750516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Are T1c tumors different from incidental tumors found at autopsy? The risk and reality of overdetection.
    Belville WD
    Semin Urol Oncol; 1995 Aug; 13(3):181-6. PubMed ID: 8521130
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic characteristics of prostate cancer.
    Huncharek M; Muscat J
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):681-7. PubMed ID: 8547836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.